Adooq Bioscience
BMS-806, also known as BMS-378806 , is a type of medicine called an entry inhibitor. Entry inhibitors work by blocking HIV from entering human cells. BMS-378806 (BMS-806) is a small molecule that blocks the binding of host-cell CD4 with viral gp120 protein and therefore inhibits the first steps of HIV-1 infection.
More Information
Supplier Page
BMS-806 100mg
100mg
| Purity Not Available
Adooq Bioscience
BMS-806, also known as BMS-378806 , is a type of medicine called an entry inhibitor. Entry inhibitors work by blocking HIV from entering human cells. BMS-378806 (BMS-806) is a small molecule that blocks the binding of host-cell CD4 with viral gp120 protein and therefore inhibits the first steps of HIV-1 infection.
More Information
Supplier Page
BMS-806 10mg
10mg
| Purity Not Available
Adooq Bioscience
BMS-806, also known as BMS-378806 , is a type of medicine called an entry inhibitor. Entry inhibitors work by blocking HIV from entering human cells. BMS-378806 (BMS-806) is a small molecule that blocks the binding of host-cell CD4 with viral gp120 protein and therefore inhibits the first steps of HIV-1 infection.
More Information
Supplier Page
DCC-2036 50mg
50mg
| Purity Not Available
Adooq Bioscience
DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.
More Information
Supplier Page
DCC-2036 5mg
5mg
| Purity Not Available
Adooq Bioscience
DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.
More Information
Supplier Page
Adooq Bioscience
DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.
More Information
Supplier Page
DCC-2036 100mg
100mg
| Purity Not Available
Adooq Bioscience
DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.
More Information
Supplier Page
DCC-2036 10mg
10mg
| Purity Not Available
Adooq Bioscience
DCC-2036 is an orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity.
More Information
Supplier Page
A 922500 50mg
50mg
| Purity Not Available
Adooq Bioscience
A 922500 is a diacylglycerol acyltransferase 1 (DGAT-1) inhibitor (IC50 values are 7 and 24 nM at human and mouse DGAT-1 respectively).
More Information
Supplier Page
KW-2478 10mg
10mg
| Purity Not Available
Adooq Bioscience